SCHEMBL450264

SCHEMBL450264

CCC[n+]1ccccc1-c1c2nc(c(-c3cccc[n+]3CCC)c3ccc([nH]3)c(-c3cccc[n+]3CCC)c3nc(c(-c4cccc[n+]4CCC)c4ccc1[nH]4)C=C3)C=C2

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 6/20 0.48
▸ TOP1 P11387 2/20 0.35
▸ CYCS P99999 2/20 0.35
▸ ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL452379 0.92 TERT (0.46) TERTTOP1
SCHEMBL453031 0.90 TERT (0.52) TERTTOP1CYCSENPP2
SCHEMBL451943 0.89 NPC1 (0.45) TERT
SCHEMBL448359 0.89 NPC1 (0.45) TERT
SCHEMBL449176 0.89 NPC1 (0.45) TERT
SCHEMBL30096016 0.89 NPC1 (0.45) TERT
SCHEMBL452116 0.89 NPC1 (0.45) TERT
SCHEMBL4914167 0.89 TERT (0.51) TERTTOP1CYCSENPP2
SCHEMBL29935687 0.89 TERT (0.51) TERTTOP1CYCSENPP2
SCHEMBL29935401 0.88 NPC1 (0.44) TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065181-A1 METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS DUKE UNIVERSITY 2012-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065181-A1 METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS SOD1, PYGB, PSAP TERT 4141/4885TOP1 3060/4885CYCS 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback